Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Fretz

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Medicinal Chemistry|August 28, 1998
Structure-based design and synthesis of high affinity tripeptide ligands of the Grb2-SH2 domainP Furet, B Gay, G Caravatti, et al.
Biochemical and Biophysical Research Communications|September 7, 2000
Inhibition of cyclin-dependent kinase 4 (Cdk4) by fascaplysin, a marine natural productR Soni, L Muller, P Furet, et al.
Journal of Molecular Biology|June 27, 1998
Structural basis for the high affinity of amino-aromatic SH2 phosphopeptide ligandsJ Rahuel, C García-Echeverría, P Furet, et al.
Biochemistry|May 13, 1997
Dual specificity of Src homology 2 domains for phosphotyrosine peptide ligandsB Gay, P Furet, C García-Echeverría, et al.
Journal of the National Cancer Institute|March 22, 2001
Selective in vivo and in vitro effects of a small molecule inhibitor of cyclin-dependent kinase 4R Soni, T O'Reilly, P Furet, et al.
Nature Structural Biology|July 1, 1996
Structural basis for specificity of Grb2-SH2 revealed by a novel ligand binding modeJ Rahuel, B Gay, D Erdmann, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2000
Structure-based design and synthesis of phosphinate isosteres of phosphotyrosine for incorporation in Grb2-SH2 domain inhibitors. Part 1P Furet, G Caravatti, A A Denholm, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Medicinal Chemistry|August 28, 1998
Structure-based design and synthesis of high affinity tripeptide ligands of the Grb2-SH2 domainP Furet, B Gay, G Caravatti, et al.
Biochemical and Biophysical Research Communications|September 7, 2000
Inhibition of cyclin-dependent kinase 4 (Cdk4) by fascaplysin, a marine natural productR Soni, L Muller, P Furet, et al.
Journal of Molecular Biology|June 27, 1998
Structural basis for the high affinity of amino-aromatic SH2 phosphopeptide ligandsJ Rahuel, C García-Echeverría, P Furet, et al.
Biochemistry|May 13, 1997
Dual specificity of Src homology 2 domains for phosphotyrosine peptide ligandsB Gay, P Furet, C García-Echeverría, et al.
Journal of the National Cancer Institute|March 22, 2001
Selective in vivo and in vitro effects of a small molecule inhibitor of cyclin-dependent kinase 4R Soni, T O'Reilly, P Furet, et al.
Nature Structural Biology|July 1, 1996
Structural basis for specificity of Grb2-SH2 revealed by a novel ligand binding modeJ Rahuel, B Gay, D Erdmann, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2000
Structure-based design and synthesis of phosphinate isosteres of phosphotyrosine for incorporation in Grb2-SH2 domain inhibitors. Part 1P Furet, G Caravatti, A A Denholm, et al.
Pageof 2